Premium
Parenteral iron therapy options
Author(s) -
Silverstein Scott B.,
Rodgers George M.
Publication year - 2004
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20056
Subject(s) - iron sucrose , medicine , iron deficiency , anemia , iron therapy , parenteral nutrition , anaphylaxis , intravenous iron , erythropoietin , iron deficiency anemia , intensive care medicine , surgery , gastroenterology , immunology , allergy
Parenteral iron therapy is occasionally necessary for patients intolerant or unresponsive to oral iron therapy, for receiving recombinant erythropoietin therapy, or for use in treating functional iron deficiency. There are now three parenteral iron products available: iron dextran, ferric gluconate, and iron sucrose. We summarize the advantages and disadvantages of each product, including risk of anaphylaxis and hypersensitivity, dosage regimens, and costs. The increased availability of multiple parenteral iron preparations should decrease the need to use red cell transfusions in patients with iron‐deficiency anemia. Am. J. Hematol. 76:74–78, 2004. © 2004 Wiley‐Liss, Inc.